Premium
The effects of depolarizing agents and neuropeptides on dopamine release from striatal synaptosomes
Author(s) -
VonVoigtlander Philip F.,
Losey Elizabeth G.
Publication year - 1982
Publication title -
drug development research
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.582
H-Index - 60
eISSN - 1098-2299
pISSN - 0272-4391
DOI - 10.1002/ddr.430020411
Subject(s) - dopamine , chemistry , depolarization , substance p , neuropeptide , medicine , veratridine , cholecystokinin , neurotransmitter , endocrinology , striatum , pharmacology , receptor , biology , biochemistry , sodium , organic chemistry , sodium channel
Synaptosomes (isolated nerve endings) from rat corpus striatum responded to several depolarizing agents by releasing dopamine. Among these agents were KCl, glutamic acid, ouabain, and veratrine. Substance P hexapeptide (SP6) also caused dopamine release, but the magnitude of this effect was small and variable. A number of other neuropeptides (cholecystokinin 1–8, des‐Tyr‐γ‐endorphin, Leu 5 ‐β‐endorphin and substance P) did not alter dopamine release. SP6‐induced dopamine release may result from substance P receptor‐induced depolarization; however, the lack of robustness of the response in this preparation makes it unsuitable for studying agonists and antagonists of substance P.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom